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Development of a Desktop Reference
for Medication Assisted Treatment
Andrew Darling, PhD
Berlin Family Practice
Preceptors: Dale Stafford, MD, Lise Kowalski, MD, Jose Lopez,
MD, Brian Rodriguez, MD

2. Problem Identification
• In treatment of patients with substance use disorder, family medicine physicians can work
closely with a multidisciplinary medication assisted treatment (MAT) team, providing
recovery support alongside medical care. These teams have expertise in community
resources, drug screening, withdrawal, and psychological counseling. Physicians often need
to direct patients to MAT programs.
• Reference material on MAT can be widely distributed, with multiple sources often consulted
for a patient with substance use disorders, including morphine equivalents, urine drug
screening, and tapering strategies.
• Time is short in the clinic, and a single resource that could provide contact information for
MAT resources alongside frequently cited medical information could expedite care. This
would be doubly valuable for physicians new to the region.

3. Public Health Cost
• Opioid related fatalities in Vermont have nearly
tripled since 2010, 110 deaths in 2018, driven in part
by fentanyl fatality increases.
• 2.6% of Vermonters between 18 and 64 years old
participated in MAT programs in 2018.
• MAT availability has increased such that supply has
now met demand, without wait times prior to hub
services. Focus is now on increasing entry points,
such as emergency rooms, i.e. the Rapid Access to
MAT (RAM) program.

Opioid Related Fatalities among Vermonters, February 2019
https://www.healthvermont.gov/

Medication Assisted Treatment for Opioid Use Disorder Trends,
2019, https://www.healthvermont.gov/

4. Community Perspective on Issue
• A design input solicitation email was sent to practitioners at Berlin Family Practice, seeking
information they frequently reference for MAT patients, either medical information or
community resources.
• Interviews were conducted with several stakeholders involved with MAT patients,
specifically asking them about content and application of a single-sheet double sided
Desktop Reference.
•

•

Laurie Hansen, MAT RN, CVMC – Provided substantial content for both the physician fact sheet side (Narcan dosages and
acquisition, screening guides such as COWS for withdrawal screening and OBOT Stability Index) as well as detailed patient
resources for where they can find aid. This included the hub procedures at facilities like BAART Program, Rapid Access to
MAT (RAM) program at which patients can receive immediate assistance while in withdrawal, and Treatment Associates
which “operates like something between a hub and a spoke.”
Jeremiah Eckhaus, MD, CVMC – Discussed how such a document could be used by family medicine physicians throughout
the state, in either hardcopy or electronic format. He suggested that with the integration of more facilities into the UVM
Health Network and the EMR, the resource document could be made available as a software add-on. “This is the sort of
thing that if it was widely adopted could be added to Epic.”

5A. Intervention
Provider Fact Sheet
• The drafted Vermont Medication Assisted Desk
Reference is a single 2-sided sheet, intended to
be laminated and available for everyday use.
• The greatest challenge was deciding what could
be included in limited space.
• One side, the healthcare provider fact sheet has
medical information often used by physicians:
• Morphine equivalents
• Urine detection timetables
• Tapering rates
• Severity indices
• Appropriate links for comprehensive
information
5

5B. Intervention
Provider Fact Sheet
• The second side, the patient fact sheet includes a
number of features relevant to the patient
themselves:
• Locations and contact numbers for MAT hubs
throughout the state
• Where one can go while currently in
withdrawal, including a description of Rapid
Access to MAT, an emergency room program
available for actively withdrawing patients.
This also includes the crisis text line.
• Sources for naloxone, including a link to the
online map service provided by the state, and
recommendations for naloxone usage.
6

6A Results – Design Feedback
• An online design review was conducted, soliciting feedback from MAT stakeholders, with
generally positive response and suggestions for future iterations:
• “This is something which is going to be used. Even just the windows for detection of
drugs in urine are very useful.” – Dale Stafford, Family Physician
• “Good, short document. Easy to read and has useful information. The table with
metabolites and half lives is clinically relevant.” – Jose Lopez, Family Physician
• “I would also add induction protocols and how long the presence of illicit substances
(such as cocaine) are in the urine.” – Anonymous, Vermont physician with MAT
experience
• “I think it is important to even briefly mention that the 2 part Hub and Spoke includes
counseling and recovery support.” – Katina Cummings, MCP, Health Workforce
Program Manager, Northern Vermont AHEC

6B Results – 2nd Design Iteration
• Drafts were distributed to contributors to the
design process, and an early request was
received to make a second version of the desktop
reference focused on Central Vermont’s MAT
resources, which is shown here.
• While having an identical physician fact sheet,
the patient fact sheet of this version has local
MAT induction information, including walk-in
clinic hours most relevant for central Vermont.
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7A. Evaluation of Effectiveness and Limitations
• As the MAT Desktop Reference is an easily distributable document, in either hardcopy or
electronic format, an evaluation of its usefulness could be conducted through distribution to
stakeholders through an online survey. This could include PCPs and MAT professionals.
• Information solicited in these surveys should include:
• Assessment of perceived value of the medical information from the provider fact sheet
(quantized for each section)
• Assessment of perceived value of the patient fact sheet (quantized for each section)
• Suggestions for information that should be added
• Suggestions for information that is not necessary

8. Opportunities for Future Interventions
• Distribution of this, or an abridged MAT reference, to school health
professionals, such as school nurses, to improve treatment for youth
opioid use disorder.
• Augmented references focused on individual counties and their
particular needs.
• Alternative desk references in a similar style produced for other
community health issues, such as medical supply availability or home
health services.
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VERMONT MEDICATION ASSISTED TREATMENT
HEALTHCARE PROVIDER FACT SHEET
DSM-5 Criteria for Opioid Use Disorder

Tapering Guidelines

A pattern of opioid use leading to clinically significant
impairment or distress, as manifested by at least 2 of the
following within a 12-month period. Severity as follows:
Mild: Presence of 2-3 symptoms
Moderate: Presence of 4-5 symptoms
Severe: Presence of 6 or more symptoms

• Common tapers - 5% to 20% reduction every 4 weeks
• Slower tapers - 10% per 4 weeks, better tolerated
• Fast tapers - 10% per week until 30% of original dose
is reached, then 10% of remaining dose
• Rapid taper - Over 2-3 weeks, may be appropriate if
risks of continued use outweigh risk of withdrawal
• Ultrarapid detox under anesthesia - high risk and
should not be used
• Dysphoria, insomnia, and irritability may take weeks
or months to resolve
• Alpha-2-agonists may be used for management of
autonomic symptoms such as tachycardia.

1. Opioids are often taken in larger amounts or over a
longer period than was intended.
2. Persistent desire or unsuccessful efforts to cut down
or control opioid use.
3. A great deal of time is spent in activities necessary to
obtain, use, or recover from the effects of opioids.
4. Craving, or a strong desire or urge to use opioids.
5. Recurrent opioid use resulting in a failure to fulfill
major role obligations at work, school, or home.

HHS Guide for Clinicians on the Appropriate Dosage Reduction
or Discontinuation of Long-Term Opioid Analgesics,
US Department of Health and Human Services, October 2019

Morphine Equivalent Units/Detection Timetable
MME
30

Urine Detectability/Analyte
•11 days - metabolite norbuprenorphine

Codeine

0.15

7. Important social, occupational, or recreational activities are given up or reduced because of opioid use.

Fentanyl
derm(mcg/hr)

2.4

• 1-2 days - hydromorphone
and morphine
•2-3 days - norfentanyl

8. Recurrent opioid use in situations in which it is physically hazardous.

Hydrocodone

1

• 1-2 days - hydromorphone

Hydromorphone

4

• 1-2 days - hydromorphone

11. Withdrawal.

Methadone
• 1-20 mg/d
• 21-40 mg/d
• 41-60 mg/d
• ≥ 61-80 mg/d

4
8
10
12

abridged from Diagnostic and Statistical Manual of Mental Disorders, 5th edition, 2013

Morphine

1

Oxycodone

1.5

6. Continued opioid use despite having persistent or
recurrent social or interpersonal problems caused or
exacerbated by the effects of opioids.

9. Continued opioid use despite knowledge of a persistent/recurrent physical or psychological problem likely to have been caused or exacerbated by the substance.
10. Tolerance.

COWS
The Clinical Opiate Withdrawal Scale is a pen and paper
severity scale based up common withdrawal symptoms,
obatinable through multiple sources, including the link
below. 5-12 = mild; 13-24 = moderate; 25-36 = moderately severe; more than 36 = severe withdrawal
American Society of Addiction Medicine
https://www.asam.org/

Buprenorphine
film/tab (mg)

Oxymorphone

3

•3-4 days (as high as 14 days)
- 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine

• 3 days - Codeine, hydromorphone, 6-MAM, morphine
• 1-3 days - Noroxycodone,
noroxymorphone, oxycodone,
oxymorphone
•1.5-4 days - Noroxymorphone, oxymorphone

“Calculating Daily Total Dose of Opiods for Safer Dosage,” www.
cdc.gov, August 2019
Kale, N. “Urine Drug Tests: Ordering and Interpretation,” American Family Physician, 2019 Jan 1;99(1):33-39
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VERMONT MEDICATION ASSISTED TREATMENT
STATEWIDE PATIENT FACT SHEET
Where can I begin MAT?

I’m in withdrawal right now. What can I do?

You can receive live help to find treatment programs by
dialing 2-1-1 in Vermont or visiting Vermont211.org.

If you’re in crisis, you can reach the Vermont Crisis text
line. Text VT to 741741.

Medication Assisted Treatment (MAT) uses a “hub-andspoke” model and starts at an Opioid Treatment Hub,
where you will be evaluated and begin receiving medications such as buprenorphine to prevent withdrawal and
reduce cravings. Eventually, your medications will be
managed at the “spoke” office that is most convenient for
you. Please bring ID and be prepared to submit a urine
sample - the screening evaluation takes 1-2 days. Hubs
where you can begin treatment are listed below:

Rapid Access to MAT (RAM) is a program available at
many emergency departments across the state, including UVMMC, CVMC, and Rutland. RAM allows for
same-day treatment with buprenorphone to control
withdrawal, while you are referred to a MAT provider
and connected with a Recovery Coach. Questions about
RAM and whether it’s available in an emergency room
near you can be answered by the confidential clinician’s
line, (802)371-4190.

Chitenden county
• Howard Center, Burlington and South Burlington
(802)488-6425
Franklyn and Grand Isle Counties
• BAART Behavioral Health Services, St. Albans
(802)370-3545
Orleans, Essex, & Caledonia County
• BAART Behavioral Health Services, Newport
(802)334-0110
• BAART Behavioral Health Services, St. Johnsbury
(802)748-6166
Rutland County
• West Ridge Center for Addiction Recovery, Rutland
(802)776-5800
Washington County
• Central Vermont Addiction Center, Berlin
(802)223-2003
Windham County
• Brattleboro Retreat, Brattleboro
(802)257-7785
• Habit OpCo, Brattleboro
(802)349-1880
New Hampshire
• Habit OpCo, West Lebanon
(603)298-2146
“Vermont Substance Abuse Treatment & Recovery Directory”
Division of Alcohol & Drug Abuse Programs

Rapid Access to MAT, https://cvmc.org/our-services/emergency-department/rapid-access-mat-ram

Where can I get Narcan®/naloxone?
WARNING - You may need two or more doses
available. It’s advisable to have multiple naloxone doses
on hand, due to the overdose potential of fentanyl and
fentanyl-contaminated drugs. It is not uncommon for
a person in overdose to respond to a first dose of naloxone only to lose consciousness once again and require a
second dose.
WARNING - Call 9-1-1 after administering a dose of
Narcan to anyone. The person may not be stable, and
it’s state law to help keep them safe. You are immune
from civil or criminal liability when giving naloxone, so
long as you don’t act recklessly, with gross negligence, or
intentional misconduct.
Where you can get naloxone:
• All pharmacies in Vermont are required to make
naloxone available on request, but there may be some
charge. Medicaid or insurance may apply.
• The Opioid Overdose Prevention and Reversal Project
makes emergency overdose rescue kits and overdose
response training available free of charge at a range of
locations. A list and map of locations may be found at
the web address below.
NARCAN/NALOXONE OVERDOSE RESCUE
https://www.healthvermont.gov/response/alcohol-drugs/narcan-naloxone-overdose-res
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VERMONT MEDICATION ASSISTED TREATMENT
CENTRAL VT PATIENT FACT SHEET
Where can I begin MAT?

I’m in withdrawal right now. What can I do?

You can receive live help to find treatment programs by
dialing 2-1-1 in Vermont or visiting Vermont211.org.

If you’re in crisis, you can reach the Vermont Crisis text
line. Text VT to 741741.

Medication Assisted Treatment (MAT) uses a “hub-andspoke” model and starts at an Opioid Treatment Hub,
where you will be evaluated and begin receiving medications such as buprenorphine to prevent withdrawal and
reduce cravings. Eventually, your medications will be
managed at the “spoke” office that is most convenient for
you. Please bring ID and be prepared to submit a urine
sample - the screening evaluation takes 1-2 days.

Rapid Access to MAT (RAM) is a program available at
many emergency departments across the state, including CVMC. RAM allows for same-day treatment
with buprenorphone to control withdrawal, while you
are referred to a MAT provider and connected with a
Recovery Coach. Questions about RAM and whether
it’s available in an emergency room near you can be
answered by the confidential clinician’s line, (802)3714190.

Specific options in Central Vermont can be seen below.
For beginning MAT, known as induction, it is recommended to visit one of the walk-in clinics.
BAART Programs Berlin
617 Comstock Rd, Suite 5
Berlin, VT 05602
(802)223-2003
Walk-in Clinic Hours: Monday - Friday 7am - 8pm
Treatment Associates, Inc. - Montpelier Office
73 Main Street, Suite 27
Montpelier, VT 05602
(802)225-8355
Walk-in Clinic Hours: Tues & Thurs 1:30 - 2:30pm
Treatment Associates, Inc. - Morrisville Office
65 Portland Street, PO Box 1099
Morrisville, VT 05661
(802)888-0079
Walk-in Clinic Hours: Tues & Thurs 1:30 - 2:30pm
CVMC MAT Program
84 East View Lane, Suite 2
Barre VT 05641
(802)371-4875
Hours 8AM - 4:30 PM
Gifford Healthcare
44 South Main Street
Randolph, VT 05060
(802)728-7000
“Vermont Substance Abuse Treatment & Recovery Directory”
Division of Alcohol & Drug Abuse Programs

Rapid Access to MAT, https://cvmc.org/our-services/emergency-department/rapid-access-mat-ram

Where can I get Narcan®/naloxone?
WARNING - You may need two or more doses
available. It’s advisable to have multiple naloxone doses
on hand, due to the overdose potential of fentanyl and
fentanyl-contaminated drugs. It is not uncommon for
a person in overdose to respond to a first dose of naloxone only to lose consciousness once again and require a
second dose.
WARNING - Call 9-1-1 after administering a dose of
Narcan to anyone. The person may not be stable, and
it’s state law to help keep them safe. You are immune
from civil or criminal liability when giving naloxone, so
long as you don’t act recklessly, with gross negligence, or
intentional misconduct.
Where you can get naloxone:
• All pharmacies in Vermont are required to make
naloxone available on request, but there may be some
charge. Medicaid or insurance may apply.
• The Opioid Overdose Prevention and Reversal Project
makes emergency overdose rescue kits and overdose
response training available free of charge at a range of
locations. A list and map of locations may be found at
the web address below.
NARCAN/NALOXONE OVERDOSE RESCUE
https://www.healthvermont.gov/response/alcohol-drugs/narcan-naloxone-overdose-res
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